BRAIN Biotech AG
LSE:0RFI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BRAIN Biotech AG
LSE:0RFI
|
DE |
|
Orora Ltd
ASX:ORA
|
AU |
|
M
|
Midera Food Processing Inc
NASDAQ:MFP
|
US |
|
Agora Inc
NASDAQ:API
|
CN |
|
F
|
Farmacosmo SpA
MIL:COSMO
|
IT |
|
L
|
Leifheit AG
XHAM:LEI
|
DE |
|
K
|
Knowit AB (publ)
LSE:0GNK
|
SE |
|
Cerillion PLC
F:1VW
|
UK |
Wall St Price Targets
0RFI Price Targets Summary
BRAIN Biotech AG
According to Wall Street analysts, the average 1-year price target for 0RFI is 5.97 EUR with a low forecast of 5.37 EUR and a high forecast of 7.26 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RFI's stock price target?
Price Target
5.97
EUR
According to Wall Street analysts, the average 1-year price target for 0RFI is 5.97 EUR with a low forecast of 5.37 EUR and a high forecast of 7.26 EUR.
What is the Revenue forecast for BRAIN Biotech AG?
Projected CAGR
10%
Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for BRAIN Biotech AG?
Projected CAGR
9%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 9%.
